Cohort1: ALN-TTRSC
|
Administration route |
subcutaneous injection |
Pts |
140 |
Age |
Adult, Older_Adult |
Outcome |
6 Minute Walk Distance (6-MWD):Overall Number of Participants Analyzed:0|Serum TTR Levels:Overall Number of Participants Analyzed:0 |
Adverse reactions |
23/140(All-cause mortality); 83/140(Blood and lymphatic system disorders; Cardiac disorders; Ear and labyrinth disorders; Gastrointestinal disorders; General disorders; Hepatobiliary disorders; Infections and infestations; Injury, poisoning and procedural complications; Metabolism and nutrition disorders; Musculoskeletal and connective tissue disorders; Neoplasms benign, malignant and unspecified(incl cysts and polyps); Nervous system disorders; Psychiatric disorders; Renal and urinary disorders; Reproductive system and breast disorders; Respiratory, thoracic and mediastinal disorders; Vascular disorders) |
References |
PMID:
32062791
|
|
Cohort2: Sterile Normal Saline
|
Administration route |
subcutaneous injection |
Pts |
66 |
Age |
Adult, Older_Adult |
Outcome |
6 Minute Walk Distance (6-MWD):Overall Number of Participants Analyzed:0|Serum TTR Levels:Overall Number of Participants Analyzed:0 |
Adverse reactions |
7/66(All-cause mortality); 34/66(Blood and lymphatic system disorders; Cardiac disorders; Gastrointestinal disorders; General disorders; Infections and infestations; Injury, poisoning and procedural complications; Metabolism and nutrition disorders; Musculoskeletal and connective tissue disorders; Neoplasms benign, malignant and unspecified(incl cysts and polyps); Nervous system disorders; Renal and urinary disorders; Respiratory, thoracic and mediastinal disorders; Skin and subcutaneous tissue disorders; Surgical and medical procedures; Vascular disorders) |
References |
PMID:
32062791
|
|